open access

Online first
Clinical vignette
Published online: 2022-06-07
Get Citation

An optimized long QT syndrome differentiating protocol: A new indication for wearable cardioverter-defibrillator vests

Marcin Pilawa1, Jarosław Kaźmierczak1, Radosław Marek Kiedrowicz1
DOI: 10.33963/KP.a2022.0142
·
Pubmed: 35677993
Affiliations
  1. Department of Cardiology, Pomeranian Medical University, Szczecin, Poland

open access

Online first
Clinical vignette
Published online: 2022-06-07

Abstract

Not available

Abstract

Not available
Get Citation
About this article
Title

An optimized long QT syndrome differentiating protocol: A new indication for wearable cardioverter-defibrillator vests

Journal

Kardiologia Polska (Polish Heart Journal)

Issue

Online first

Article type

Clinical vignette

Published online

2022-06-07

Page views

58

Article views/downloads

56

DOI

10.33963/KP.a2022.0142

Pubmed

35677993

Authors

Marcin Pilawa
Jarosław Kaźmierczak
Radosław Marek Kiedrowicz

References (5)
  1. Priori SG, Blomström-Lundqvist C, Mazzanti A, et al. 2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: The Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of the European Society of Cardiology (ESC). Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC). Eur Heart J. 2015; 36(41): 2793–2867.
  2. Wallace E, Howard L, Liu M, et al. Long QT syndrome: genetics and future perspective. Pediatr Cardiol. 2019; 40(7): 1419–1430.
  3. Sasaoka S, Matsui T, Hane Y, et al. Time-to-Onset analysis of drug-induced long QT syndrome based on a spontaneous reporting system for adverse drug events. PLoS One. 2016; 11(10): e0164309.
  4. Sandhu U, Rajyaguru C, Cheung CC, et al. The wearable cardioverter-defibrillator vest: Indications and ongoing questions. Prog Cardiovasc Dis. 2019; 62(3): 256–264.
  5. Sterliński M, Oręziak A, Przybylski A, et al. Experts of the Heart Rhythm Section of the Polish Cardiac Society: opinion on the use of wearable cardioverter-defibrillators in Poland. Kardiol Pol. 2019; 77(2): 238–243.

Regulations

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By VM Media Sp. z o.o. VM Group Sp.k., ul. Świętokrzyska 73 , 80–180 Gdańsk, Poland

phone:+48 58 320 94 94, fax:+48 58 320 94 60, e-mail: viamedica@viamedica.pl